Mimedx Group, Inc. balance sheet
At the end of fiscal 2025, Mimedx Group, Inc. had total assets of $343m, total liabilities of $86.1m and shareholders' equity of $257m. It held $166m in cash against $18.0m of debt.
Balance sheet
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1 | 4 | 30 | 27 | 45 | 69 | 96 | 87 | 66 | 82 | 104 | 166 | 121 |
| Receivables | 0 | 2 | 2 | — | 0 | 32 | 35 | 40 | 43 | 54 | 56 | 76 | 37 |
| Inventory | 0 | 1 | 16 | 9 | 16 | 9 | 10 | 11 | 13 | 21 | 24 | 25 | 22 |
| Total current assets | 2 | 7 | 59 | 49 | 74 | 123 | 161 | 149 | 134 | 164 | 192 | 277 | 187 |
| Goodwill | 1 | 4 | 20 | 20 | 20 | 20 | 20 | 19 | 19 | 19 | 19 | 19 | 19 |
| Total assets | 7 | 27 | 117 | 121 | 123 | 167 | 202 | 188 | 171 | 239 | 264 | 343 | 265 |
| Accounts payable | — | — | 11 | — | 15 | 9 | 9 | 7 | 8 | 9 | 7 | 15 | 12 |
| Deferred revenue (current) | — | — | — | — | — | — | 1 | 1 | — | — | — | — | — |
| Total current liabilities | 1 | 5 | 61 | 46 | 72 | 67 | 59 | 42 | 44 | 46 | 46 | 64 | 43 |
| Short-term debt | — | 1 | — | — | 0 | 4 | 0 | — | — | 1 | 1 | 2 | 0 |
| Long-term debt | 0 | 3 | — | — | 0 | 62 | 48 | 48 | 49 | 48 | 18 | 16 | 0 |
| Total debt | 0 | 8 | 0 | 0 | 0 | 73 | 50 | 50 | 50 | 50 | 19 | 18 | 0 |
| Total liabilities | 1 | 15 | 69 | 47 | 73 | 133 | 111 | 95 | 97 | 96 | 71 | 86 | 53 |
| Shareholders' equity | 6 | 12 | 48 | 74 | 50 | 34 | −0 | 0 | −18 | 143 | 193 | 257 | 211 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | 92 | 92 | 92 | — | — | — | — |
| Shares outstanding | 64m | 74m | 110m | 109m | 109m | 111m | 111m | 112m | 114m | 146m | 147m | 148m | 146m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 56 | 62 | 69 | 78 | 76 | 46 | 41 | 37 |
| Inventory | 24 | 24 | 25 | 27 | 25 | 26 | 21 | 22 |
| Total current assets | 192 | 200 | 221 | 254 | 277 | 240 | 205 | 187 |
| Goodwill | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Total assets | 264 | 270 | 291 | 319 | 343 | 309 | 281 | 265 |
| Accounts payable | 7 | 9 | 8 | 11 | 15 | 11 | 8 | 12 |
| Total current liabilities | 46 | 43 | 50 | 58 | 64 | 45 | 38 | 43 |
| Short-term debt | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 0 |
| Long-term debt | 18 | 18 | 17 | 17 | 16 | 16 | 16 | 0 |
| Total debt | 19 | 19 | 18 | 18 | 18 | 18 | 17 | 0 |
| Total liabilities | 71 | 68 | 74 | 80 | 86 | 66 | 65 | 53 |
| Shareholders' equity | 193 | 203 | 217 | 239 | 257 | 243 | 216 | 211 |
| Shares outstanding | 147m | 148m | 148m | 148m | 148m | 149m | 146m | 146m |
Compare with peers
- Organogenesis Holdings Inc. balance sheet
- UFP Technologies Inc balance sheet
- Orasure Technologies Inc balance sheet
- Embecta Corp. balance sheet
- ICU Medical Inc balance sheet
Head to head: MDXG vs ORGOMDXG vs UFPTMDXG vs OSUR
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies